Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 61-68 , January 2011

Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity

  • Dolores Mahmud

      Affiliations

    • Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Benedetta Nicolini

      Affiliations

    • Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Lennert van den Dries

      Affiliations

    • Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Nadim Mahmud

      Affiliations

    • Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois
    • University of Illinois at Chicago Cancer Center, Chicago, Illinois
    • ,
  • Mario Arpinati

      Affiliations

    • Department of Hematology/Oncology “Seragnoli,” University of Bologna, Italy
    • ,
  • Damiano Rondelli

      Affiliations

    • Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois
    • University of Illinois at Chicago Cancer Center, Chicago, Illinois
    • Corresponding Author InformationCorrespondence and reprint requests to: Damiano Rondelli, MD, Section of Hematology/Oncology, University of Illinois at Chicago, 909 S. Wolcott Ave. (MC734), Chicago, IL 60612.

Received 28 May 2010 ,Accepted 4 August 2010.

References 

  1. Mattason J, Ringden O, Storb S. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14(Suppl 1):165–170
  2. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186–1193
  3. Rondelli D, Andrews RG, Hansen JA, Ryncarz R, Faerber MA, Anasetti C. Alloantigen presenting function of normal human CD34+ hematopoietic cells. Blood. 1996;88:2619–2675
  4. Rondelli D, Anasetti C, Fortuna A, et al. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells. Bone Marrow Transplant. 1998;21:1183–1191
  5. Rondelli D, Lemoli RM, Ratta M, et al. Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34(+) blood cells identifies myeloid committed progenitors and permits selection of non immunogenic CD40(−) progenitor cells. Blood. 1999;94:2293–2300
  6. Abbasian J, Mahmud D, Mahmud N, et al. Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function. Blood. 2006;108:203–208
  7. Arpinati M, Terragna C, Chirumbolo G, et al. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade. Exp Hematol. 2003;31:31–38
  8. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105:2821–2827
  9. Tolar J, Hippen KL, Blazar BR. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematol. 2009;147:200–206
  10. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+FoxP3+ regulatory T Lymphocytes. Nat Med. 2008;14:88–92
  11. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562
  12. Albert MH, Liu Y, Anasetti C, Yu XZ. Antigen- dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol. 2005;35:2598–2607
  13. Finke J, Bethge WA, Schmoor C, et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol. 2009;10:855–864
  14. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FoxP3 regulatory T cells. J Am Soc Nephrol. 2006;17:2844–2853
  15. Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25 high FoxP3+ regulatory T cells in vitro. Blood. 2008;111:3675–3683
  16. Hoffmann P, Boeld TJ, Eder R, et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant. 2006;12:267–274
  17. Di Ianni M, Del Papa B, Cecchini D, et al. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol. 2009;156:246–253
  18. Kakhniashvili I, Filicko J, Kraft WK, Flomenberg N. Heterogeneous clearance of antithymocyte globulin after CD34+ selected allogeneic hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2005;11:609–618
  19. Waller EK, Langston AA, Lonial S, et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2003;9:460–471
  20. LaCorcia G, Swistak M, Lawendowski C, et al. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion. Transplantation. 2009;87:966–974
  21. Richter G, Hayden-Ledbetter M, Irgang M, et al. Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells. J Biol Chem. 2001;276:45686–45693
  22. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007;8:1353–1362
  23. Nguyen VH, Shashidhar S, Chang DS, et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood. 2008;11:945–953
  24. Urbieta M, Barao I, Jones M, et al. Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. Blood. 2010 Mar 3;[Epub ahead of print]
  25. Liu Z, Fang Y, Wang X, Wang P, Yun P, Xu H. Upregulation of molecules associated with T-regulatory function by thymoglobulin pretreatment of human CD4+ cells. Transplantation. 2008;86:1419–1426
  26. Menning A, Hopken HE, Siegmund K, Lipp M, Hamann A, Huehn J. Distinctive role of CCR7 in migration and functional activity of naïve and effector/memory-like Treg subsets. Eur J Hematol. 2007;37:1575–1583
  27. Koenecke C, Czeloth N, Bubke A, et al. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol. 2009;39:3091–3096
  28. Di Ianni M, Falzetti F, Carotti A, et al. Adoptive immunotherapy with Tregs prevents GvHD and favours immune reconstitution after HLA haploidentical transplants for hematological malignancies. Blood. 2009;114:4;(abstr.)

 Financial disclosure: See Acknowledgments on page 67.

PII: S1083-8791(10)00343-5

doi: 10.1016/j.bbmt.2010.08.004

Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 61-68 , January 2011

Article Tools

* Image Usage & Resolution